Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: Potential involvement of endogenous morphine in the pathophysiology of schizophrenia-Reference-Cited by-同舟云学术

Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: Potential involvement of endogenous morphine in the pathophysiology of schizophrenia

Published:2012 Issue:7 Volume:18 Page:HY23-HY26
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Stefano George B.¹,Králíčková Milena²,Ptacek Radek³,Kuzelova Hana⁴,Esch Tobias⁵,Kream Richard M.¹

Affiliation:

1. Neuroscience Research Institute, State University of New York – College at Old Westbury, Old Westbury, NY, U.S.A.

2. Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University in Prague, Czech Republic

3. Clinic of Psychiatry, 1st Faculty of Medicine, Charles University in Prague, Czech Republic

4. Clinic of Psychiatry, 1st Faculty of Medicine, Charles University in Prague, Czech Republic and Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic

5. Neuroscience Research Institute, State University of New York – College at Old Westbury, Old Westbury, NY, U.S.A. and Division of Integrative Health Promotion, Coburg University of Applied Sciences, Germany

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal morphine intake during pregnancy and lactation affects the circadian clock of rat pups;Brain Research Bulletin;2021-12

2. Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review;EUR REV MED PHARMACO;2021

3. Emerging regulatory roles of opioid peptides, endogenous morphine, and opioid receptor subtypes in immunomodulatory processes: Metabolic, behavioral, and evolutionary perspectives;Immunology Letters;2020-11

4. Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up;Medical Science Monitor;2020-09-06

5. Variations and expression features of CYP2D6 contribute to schizophrenia risk;Molecular Psychiatry;2020-02-11